Symptom based ICS effective for asthma

US researchers divided almost 300 adult patients into three groups with medication adjusted on the basis of physician assessment, exhaled nitric oxide levels or symptoms, with the latter arm instructed to take a matched dose of ICS and rescue albuterol.

The study found no significant difference among the groups in the time to treatment failure over nine months’ follow-up.

“This is not a treatment breakthrough but it may possibly open the door to a new approach to treatment, and it will certainly be considered by the expert panel for